Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses.
- Journal Article
Summary
This research paper assesses and provides insight into an outbreak of West Nile virus (WNV) encephalomyelitis in a horse population in Texas during 2002 that had not been previously exposed to the virus. The study uncovers various aspects of the outbreak, including the phases of the epidemic, disease clusters, recent travel history of affected horses, vaccination status, survival rate, and commonly reported signs of the disease.
Epidemiological Analysis of WNV Encephalomyelitis Outbreak
This study undertakes a comprehensive analysis of equine West Nile virus (WNV) encephalomyelitis cases reported in Texas in 2002, which is based on clinical signs and ELISA serology tests.
- The epidemic occurred between June 27 to December 17, peaking in early October and affecting around 1,698 horses.
- The study identifies three distinct phases of the epidemic that majorly occurred in southeast, northwest, and central Texas.
- Two significant disease clusters were identified in northwest and northern Texas.
Travel and Vaccination History of Affected Horses
The research also delves into the travel and vaccination history of the affected horses, as these factors could potentially influence the spread and severity of the disease.
- It is noted that a majority (91.1%) of the horses afflicted by the disease had no recent travel history.
- About 68.9% of the afflicted horses had not been vaccinated within the previous 12 months.
Survival Rate and Clinical Signs
The survival rate and the symptoms presented by afflicted horses were also scrutinized.
- The study reports a low survival rate with one-third of the horses not surviving the outbreak.
- The majority of the horses that died (71.2%) were actually euthanized.
- The most common clinical signs observed in horses included ataxia (lack of muscle control – 69%), abnormal gait (52%), muscle fasciculations (involuntary muscle twitching – 49%), depression (32%), and recumbency (lying down – 28%).
Disease Risk Factors and Prognosis
In terms of risk factors and prognosis, the paper illustrates the impact of specific variables on disease progression and mortality.
- Vaccination status, ataxia, falling down, recumbency and lip droop were found to have significant influence on the chances of a horse not surviving the disease.
- The study also asserts the varying peak risk period for encephalomyelitis caused by WNV across different regions within Texas.
- The prognosis for recumbent horses was observed to be poor.
Role of Vaccination
The role of vaccinations in potentially mitigating the risk of death was also examined.
- Even if not administered adequately in advance of WNV infection within a district, vaccines were found to reduce the risk of death by at least 44%.
Cite This Article
Publication
Researcher Affiliations
- Department of Veterinary Integrative Biosciences, MS 4458, Texas A&M University, College Station, TX 77843-4458, USA. mward@cvm.tamu.edu
MeSH Terms
- Animals
- Cluster Analysis
- Disease Outbreaks / veterinary
- Encephalomyelitis / epidemiology
- Encephalomyelitis / mortality
- Encephalomyelitis / veterinary
- Encephalomyelitis / virology
- Female
- Geography
- Horse Diseases / epidemiology
- Horse Diseases / mortality
- Horse Diseases / virology
- Horses
- Male
- Prognosis
- Risk Factors
- Seasons
- Texas / epidemiology
- Time Factors
- West Nile Fever / epidemiology
- West Nile Fever / mortality
- West Nile Fever / veterinary
- West Nile Fever / virology
- West Nile Virus Vaccines / administration & dosage
- West Nile Virus Vaccines / immunology
- West Nile virus / isolation & purification
Citations
This article has been cited 16 times.- Bruno L, Nappo MA, Frontoso R, Perrotta MG, Di Lecce R, Guarnieri C, Ferrari L, Corradi A. West Nile Virus (WNV): One-Health and Eco-Health Global Risks. Vet Sci 2025 Mar 19;12(3).
- García-Carrasco JM, Muñoz AR, Olivero J, Segura M, García-Bocanegra I, Real R. West Nile virus in the Iberian Peninsula: using equine cases to identify high-risk areas for humans. Euro Surveill 2023 Oct;28(40).
- Schwarz ER, Long MT. Comparison of West Nile Virus Disease in Humans and Horses: Exploiting Similarities for Enhancing Syndromic Surveillance. Viruses 2023 May 24;15(6).
- Fehér OE, Fehérvári P, Tolnai CH, Forgách P, Malik P, Jerzsele Á, Wagenhoffer Z, Szenci O, Korbacska-Kutasi O. Epidemiology and Clinical Manifestation of West Nile Virus Infections of Equines in Hungary, 2007-2020. Viruses 2022 Nov 18;14(11).
- Cavalleri JV, Korbacska-Kutasi O, Leblond A, Paillot R, Pusterla N, Steinmann E, Tomlinson J. European College of Equine Internal Medicine consensus statement on equine flaviviridae infections in Europe. J Vet Intern Med 2022 Nov;36(6):1858-1871.
- Ganzenberg S, Sieg M, Ziegler U, Pfeffer M, Vahlenkamp TW, Hörügel U, Groschup MH, Lohmann KL. Seroprevalence and Risk Factors for Equine West Nile Virus Infections in Eastern Germany, 2020. Viruses 2022 May 30;14(6).
- Stander J, Chabeda A, Rybicki EP, Meyers AE. A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice. Front Plant Sci 2021;12:738619.
- Levasseur A, Arsenault J, Paré J. Surveillance of West Nile virus in horses in Canada: A retrospective study of cases reported to the Canadian Food Inspection Agency from 2003 to 2019. Can Vet J 2021 May;62(5):469-476.
- Ronca SE, Ruff JC, Murray KO. A 20-year historical review of West Nile virus since its initial emergence in North America: Has West Nile virus become a neglected tropical disease?. PLoS Negl Trop Dis 2021 May;15(5):e0009190.
- Bertram FM, Thompson PN, Venter M. Epidemiology and Clinical Presentation of West Nile Virus Infection in Horses in South Africa, 2016-2017. Pathogens 2020 Dec 30;10(1).
- Byas AD, Ebel GD. Comparative Pathology of West Nile Virus in Humans and Non-Human Animals. Pathogens 2020 Jan 7;9(1).
- Venter M, Pretorius M, Fuller JA, Botha E, Rakgotho M, Stivaktas V, Weyer C, Romito M, Williams J. West Nile Virus Lineage 2 in Horses and Other Animals with Neurologic Disease, South Africa, 2008-2015. Emerg Infect Dis 2017 Dec;23(12):2060-2064.
- Faverjon C, Andersson MG, Decors A, Tapprest J, Tritz P, Sandoz A, Kutasi O, Sala C, Leblond A. Evaluation of a Multivariate Syndromic Surveillance System for West Nile Virus. Vector Borne Zoonotic Dis 2016 Jun;16(6):382-90.
- Marka A, Diamantidis A, Papa A, Valiakos G, Chaintoutis SC, Doukas D, Tserkezou P, Giannakopoulos A, Papaspyropoulos K, Patsoula E, Badieritakis E, Baka A, Tseroni M, Pervanidou D, Papadopoulos NT, Koliopoulos G, Tontis D, Dovas CI, Billinis C, Tsakris A, Kremastinou J, Hadjichristodoulou C, Vakalis N, Vassalou E, Zarzani S, Zounos A, Komata K, Balatsos G, Beleri S, Mpimpa A, Papavasilopoulos V, Rodis I, Spanakos G, Tegos N, Spyrou V, Dalabiras Z, Birtsas P, Athanasiou L, Papanastassopoulou M, Ioannou C, Athanasiou C, Gerofotis C, Papadopoulou E, Testa T, Tsakalidou O, Rachiotis G, Bitsolas N, Mamouris Z, Moutou K, Sarafidou T, Stamatis K, Sarri K, Tsiodras S, Georgakopoulou T, Detsis M, Mavrouli M, Stavropoulou A, Politi L, Mageira G, Christopoulou V, Diamantopoulou G, Spanakis N, Vrioni G, Piperaki ET, Mitsopoulou K, Kioulos I, Michaelakis A, Stathis I, Tselentis I, Psaroulaki A, Keramarou M, Chochlakis D, Photis Y, Konstantinou M, Manetos P, Tsobanoglou S, Mourelatos S, Antalis V, Pergantas P, Eleftheriou G. West Nile virus state of the art report of MALWEST Project. Int J Environ Res Public Health 2013 Dec 2;10(12):6534-610.
- Martín-Acebes MA, Saiz JC. West Nile virus: A re-emerging pathogen revisited. World J Virol 2012 Apr 12;1(2):51-70.
- Venter M, Human S, Zaayman D, Gerdes GH, Williams J, Steyl J, Leman PA, Paweska JT, Setzkorn H, Rous G, Murray S, Parker R, Donnellan C, Swanepoel R. Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis 2009 Jun;15(6):877-84.